insights_auto
Why is AMGN down 3,38%?
Dive Deeperchevron_right
AMGN:NASDAQ
Amgen Inc
407,27 $
arrow_downward
-3,38%(-14,24) 1D
407,99 $
arrow_upward
+0,18% (+0,72)bedtimeAfter hours
Closed: 1 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN...
Open
421,72 $
High
422,80 $
Low
407,13 $
Mkt. cap
220,18 մլրդ
Avg. vol.
2,91 մլն
Volume
2,50 մլն
Dividend
2,48%
Quarterly dividend
2,52 $
Ex-dividend date
21 օգս, 2026 թ.
P/E ratio
25,29
52-wk high
447,01 $
52-wk low
288,00 $
EPS
16,10 $
Beta
0,43
Shares outstanding
540,63 մլն
No. of employees
32 հզր
Open
421,72 $
High
422,80 $
Low
407,13 $
Mkt. cap
220,18 մլրդ
Avg. vol.
2,91 մլն
Volume
2,50 մլն
Dividend
2,48%
Quarterly dividend
2,52 $
Ex-dividend date
21 օգս, 2026 թ.
P/E ratio
25,29
52-wk high
447,01 $
52-wk low
288,00 $
EPS
16,10 $
Beta
0,43
Shares outstanding
540,63 մլն
No. of employees
32 հզր
News stories
From web sources and news partners
Zacks
·
6 ժամ առաջ
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
GuruFocus
·
6 ժամ առաջ
Amgen Inc (AMGN) Shares Fall 3.4% -- GF Value Says Still Overval
Yahoo! Finance Canada
·
7 ժամ առաջ
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
TradingKey
·
8 ժամ առաջ
Amgen Inc Stock (AMGN) Closed Down by 3.38% on Oct 1: What Investors Need To Know
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees31,5 հզր
Founded1980
HeadquartersԹաուզենդ Օուքս, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websiteamgen.com